Clover Health is trading at $5.11, up +5.99%, as of 9:40 a.m. EST on November 9, 2026; no specific catalyst was reported. - Clover Health is scheduled to present at the UBS Global Healthcare Conference at 12:30 p.m. EST; the announcement does not cite it as the cause of the move. - Third-quarter results showed revenue growth, and 2026 guidance was raised, including expected full-year GAAP net income of $25 million to $35 million. - Major indexes were rising, a plausible contributor; no specific volume data was available.
π’ Clover Health is trading 6% up
Clover Health Investments Corp
Related News
CLOV
π΄ Clover Health is trading 5.4% down
CLOV
π’ Clover Health is trading 4.6% up today after raising 2026 outlook
CLOV
π΄ Clover Health is trading 5% down today as major U.S. indexes fall more than 2.5%
CLOV
π΄ Clover Health is trading 4.05% down in pre-market on November 5, 2026 with no clear catalyst
CLOV